146 related articles for article (PubMed ID: 35404299)
1. Tumor-associated CD3- and CD8-positive immune cells in colorectal cancer: The additional prognostic value of CD8+-to-CD3+ ratio remains debatable.
Kasurinen J; Hagström J; Kaprio T; Beilmann-Lehtonen I; Haglund C; Böckelman C
Tumour Biol; 2022; 44(1):37-52. PubMed ID: 35404299
[TBL] [Abstract][Full Text] [Related]
2. High tissue expression of TLRs combined with high density of tumor infiltrating lymphocytes predicts a better prognosis in colorectal cancer patients.
Beilmann-Lehtonen I; Kasurinen J; Hagström J; Kaprio T; Böckelman C; Haglund C
PLoS One; 2023; 18(1):e0280085. PubMed ID: 36649244
[TBL] [Abstract][Full Text] [Related]
3. Clinical impact of heterogeneously distributed tumor-infiltrating lymphocytes on the prognosis of colorectal cancer.
Liu L; Long M; Su S; Wang L; Liu J
PeerJ; 2024; 12():e16747. PubMed ID: 38223758
[TBL] [Abstract][Full Text] [Related]
4. Intratumoral infiltrating lymphocytes correlate with improved survival in colorectal cancer patients: Independent of oncogenetic features.
Nazemalhosseini-Mojarad E; Mohammadpour S; Torshizi Esafahani A; Gharib E; Larki P; Moradi A; Amin Porhoseingholi M; Asadzade Aghdaei H; Kuppen PJK; Zali MR
J Cell Physiol; 2019 Apr; 234(4):4768-4777. PubMed ID: 30370522
[TBL] [Abstract][Full Text] [Related]
5. Automated assessment of CD8
Jiang D; Hveem TS; Glaire M; Church DN; Kerr DJ; Yang L; Danielsen HE
EBioMedicine; 2021 Sep; 71():103547. PubMed ID: 34479131
[TBL] [Abstract][Full Text] [Related]
6. Intratumoural-infiltrating CD4 + and FOXP3 + T cells as strong positive predictive markers for the prognosis of resectable colorectal cancer.
Kuwahara T; Hazama S; Suzuki N; Yoshida S; Tomochika S; Nakagami Y; Matsui H; Shindo Y; Kanekiyo S; Tokumitsu Y; Iida M; Tsunedomi R; Takeda S; Yoshino S; Okayama N; Suehiro Y; Yamasaki T; Fujita T; Kawakami Y; Ueno T; Nagano H
Br J Cancer; 2019 Oct; 121(8):659-665. PubMed ID: 31488881
[TBL] [Abstract][Full Text] [Related]
7. Differential gene expression of tumor-infiltrating CD8
Saleh R; Sasidharan Nair V; Toor SM; Taha RZ; Murshed K; Al-Dhaheri M; Khawar M; Petkar MA; Abu Nada M; Al-Ejeh F; Elkord E
J Immunother Cancer; 2020 Sep; 8(2):. PubMed ID: 32948653
[TBL] [Abstract][Full Text] [Related]
8. [Immune-Related Factors as Prognostic Markers for Resectable Colorectal Cancer].
Tomochika S; Kuwahara T; Suzuki N; Hazama S; Nagano H
Gan To Kagaku Ryoho; 2021 Mar; 48(3):325-330. PubMed ID: 33790150
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of immunoscore related markers in bladder cancer.
Ariafar A; Sanati A; Ahmadvand S; Shekarkhar G; Safaei A; Shayan Z; Faghih Z
BMC Urol; 2022 Aug; 22(1):133. PubMed ID: 36038861
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous analysis of tumor-infiltrating immune cells density, tumor budding status, and presence of lymphoid follicles in CRC tissue.
Markowski AR; Markowska AJ; Ustymowicz W; Pryczynicz A; Guzińska-Ustymowicz K
Sci Rep; 2022 Dec; 12(1):21732. PubMed ID: 36526699
[TBL] [Abstract][Full Text] [Related]
11. The Prognostic Significance of the Tumor-infiltrating Programmed Cell Death-1
Shibutani M; Maeda K; Nagahara H; Fukuoka T; Nakao S; Matsutani S; Hirakawa K; Ohira M
Anticancer Res; 2017 Aug; 37(8):4165-4172. PubMed ID: 28739701
[TBL] [Abstract][Full Text] [Related]
12. The in situ local immune response, tumour senescence and proliferation in colorectal cancer.
Roxburgh CS; Richards CH; Macdonald AI; Powell AG; McGlynn LM; McMillan DC; Horgan PG; Edwards J; Shiels PG
Br J Cancer; 2013 Oct; 109(8):2207-16. PubMed ID: 24022192
[TBL] [Abstract][Full Text] [Related]
13. The clinical utility of the local inflammatory response in colorectal cancer.
Richards CH; Roxburgh CS; Powell AG; Foulis AK; Horgan PG; McMillan DC
Eur J Cancer; 2014 Jan; 50(2):309-19. PubMed ID: 24103145
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the prognostic value of stromal tumor-infiltrating lymphocytes and CD3 + T cells between schistosomal and non-schistosomal colorectal cancer.
Wang W; Zhang Y; Liu J; Jing H; Lu K; Wang L; Zhu T; Xu Y; Bu D; Cheng M; Liu J; Shen W; Yao J; Huang S
World J Surg Oncol; 2023 Feb; 21(1):31. PubMed ID: 36726115
[TBL] [Abstract][Full Text] [Related]
15. Tumor infiltrating lymphocytes: an intriguing player in the survival of colorectal cancer patients.
Deschoolmeester V; Baay M; Van Marck E; Weyler J; Vermeulen P; Lardon F; Vermorken JB
BMC Immunol; 2010 Apr; 11():19. PubMed ID: 20385003
[TBL] [Abstract][Full Text] [Related]
16. The prognostic value of tumor-infiltrating lymphocytes in colorectal cancer differs by anatomical subsite: a systematic review and meta-analysis.
Zhao Y; Ge X; He J; Cheng Y; Wang Z; Wang J; Sun L
World J Surg Oncol; 2019 May; 17(1):85. PubMed ID: 31118034
[TBL] [Abstract][Full Text] [Related]
17. Combinatory statuses of tumor stromal percentage and tumor infiltrating lymphocytes as prognostic factors in stage III colorectal cancers.
Jin HY; Yoo SY; Lee JA; Wen X; Kim Y; Park HE; Kwak Y; Cho NY; Bae JM; Kim JH; Lee HS; Kang GH
J Gastroenterol Hepatol; 2022 Mar; 37(3):551-557. PubMed ID: 35018665
[TBL] [Abstract][Full Text] [Related]
18. A High RORγT/CD3 Ratio is a Strong Prognostic Factor for Postoperative Survival in Advanced Colorectal Cancer: Analysis of Helper T Cell Lymphocytes (Th1, Th2, Th17 and Regulatory T Cells).
Yoshida N; Kinugasa T; Miyoshi H; Sato K; Yuge K; Ohchi T; Fujino S; Shiraiwa S; Katagiri M; Akagi Y; Ohshima K
Ann Surg Oncol; 2016 Mar; 23(3):919-27. PubMed ID: 26564244
[TBL] [Abstract][Full Text] [Related]
19. Simplified and Optimized Immune Score for Colorectal Cancer Microenvironment.
Nakane H; Sudo T; Kawahara A; Yomoda T; Shigaki T; Fujiyoshi K; Ohchi T; Koushi K; Yoshida T; Ogata T; Fujita F; Akagi Y
Anticancer Res; 2023 Aug; 43(8):3793-3798. PubMed ID: 37500158
[TBL] [Abstract][Full Text] [Related]
20. Loss of survival advantage for deficient mismatch repair in patients with advanced colorectal cancer may be caused by changes in prognostic value of CD8+T cell.
Wang B; Li F; Guo L; Lu S; Ma J; Ma Y; Meng Y; Wang J; Zhou X; Fu W
World J Surg Oncol; 2020 Aug; 18(1):196. PubMed ID: 32767974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]